109
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males

, , , , , & show all
Pages 1483-1488 | Published online: 04 Nov 2013

References

  • WassonJHRedaDJBruskewitzRCElinsonJKellerAMHendersonWGA comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the ProstateN Engl J Med1995332275797527493
  • GravasSBachmannAReichOCritical review of lasers in benign prostatic hyperplasia (BPH)BJU Int201110771030104321438974
  • RiekenMEbinger MundorffNBonkatGWylerSBachmannAComplications of laser prostatectomy: a review of recent dataWorld J Urol2010281536220052586
  • ReichOBachmannASiebelsMHofstetterAStiefCGSulserTHigh power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patientsJ Urol2005173115816015592063
  • ElzayatEHabibEElhilaliMHolmium laser enucleation of the prostate: a size-independent new “gold standard”Urology200566Suppl 510811316194716
  • ShaoIHHouCPChenSMThe safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasiaClin Interv Aging2013826526923662050
  • ElmansyHBaazeemAKotbAHolmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 mL: preliminary results of a prospective, randomized clinical trialJ Urol2012188121622122591968
  • MadersbacherSAlivizatosGNordlingJSanzCREmbertonMde la RosetteJJEAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)Eur Urol200446554755415474261
  • RassweilerJTeberDKuntzRHofmannRComplications of transurethral resection of the prostate (TURP) – incidence, management, and preventionEur Urol2006505969979 discussion 98016469429
  • TaylorKFilgateRGuoDYMacneilFA retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugsBJU Int2011108Suppl 2455022085127
  • DescazeaudARobertGAzzousiARCommittee for lower urinary tract symptoms of the French Association of UrologyLaser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a reviewBJU Int200910391162116519154457
  • ErolACamKTekinAMemikOCobanSOzerYHigh power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasiaJ Urol200918231078108219616811
  • SeitzMSrokaRGratzkeCThe diode laser: a novel side-firing approach for laser vaporisation of the human prostate – immediate efficacy and 1-year follow-upEur Urol20075261717172217628326
  • RiekenMWylerSMüllerG589 laser vaporization of the prostate: intermediate-term follow-up with the 200 W high-intensity diode (HIDI) laser systemEur Urol Suppl200984268
  • CapitánCBlázquezCMartinMDHernándezVde la PeñaELlorenteCGreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-upEur Urol201160473473921658839
  • BachTHerrmannTRHaeckerAMichelMSGrossAThulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retentionBJU Int2009104336136419220261
  • BachTWendt-NordahlGMichelMSHerrmannTRGrossAJFeasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostateWorld J Urol200927454154519184038
  • BachTNetschCHaeckerAMichelMSHerrmannTRGrossAJThulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-upWorld J Urol2010281394319669645